- Home
- CADL vs NECB Comparison
CADL vs NECB Comparison
Compare CADL & NECB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CADL
- NECB
- Stock Information
- Founded
- CADL 1999
- NECB 1934
- Country
- CADL United States
- NECB United States
- Employees
- CADL N/A
- NECB N/A
- Industry
- CADL Biotechnology: Pharmaceutical Preparations
- NECB Savings Institutions
- Sector
- CADL Health Care
- NECB Finance
- Exchange
- CADL Nasdaq
- NECB Nasdaq
- Market Cap
- CADL 313.5M
- NECB 282.4M
- IPO Year
- CADL 2021
- NECB N/A
- Fundamental
- Price
- CADL $4.79
- NECB $21.18
- Analyst Decision
- CADL Strong Buy
- NECB
- Analyst Count
- CADL 5
- NECB 0
- Target Price
- CADL $19.80
- NECB N/A
- AVG Volume (30 Days)
- CADL 724.9K
- NECB 40.8K
- Earning Date
- CADL 08-14-2025
- NECB 10-27-2025
- Dividend Yield
- CADL N/A
- NECB 3.73%
- EPS Growth
- CADL N/A
- NECB N/A
- EPS
- CADL N/A
- NECB 3.29
- Revenue
- CADL N/A
- NECB $103,145,000.00
- Revenue This Year
- CADL N/A
- NECB $1.90
- Revenue Next Year
- CADL N/A
- NECB $6.93
- P/E Ratio
- CADL N/A
- NECB $6.52
- Revenue Growth
- CADL N/A
- NECB N/A
- 52 Week Low
- CADL $3.79
- NECB $19.75
- 52 Week High
- CADL $14.60
- NECB $31.72
- Technical
- Relative Strength Index (RSI)
- CADL 32.97
- NECB 41.12
- Support Level
- CADL $4.81
- NECB $21.22
- Resistance Level
- CADL $5.01
- NECB $21.73
- Average True Range (ATR)
- CADL 0.30
- NECB 0.57
- MACD
- CADL -0.08
- NECB -0.12
- Stochastic Oscillator
- CADL 3.18
- NECB 12.61
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About NECB NorthEast Community Bancorp Inc.
NorthEast Community Bancorp Inc operates as a community-oriented financial institution. It is principally engaged in the business of attracting deposits and investing those funds into mortgage and commercial loans. It conducts activities throughout the Northeastern United States including New York, Massachusetts, New Jersey, and Connecticut. The company offers a comprehensive line of banking products and services, including mobile banking as well as commercial real estate loans, commercial construction financing, lines of credit, and term loans. It also offers investment advisory and financial planning services.